The University of Chicago Header Logo

Connection

Mark Talamonti to Receptors, Leukotriene B4

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Receptors, Leukotriene B4.
Mark Talamonti
Connection Strength
0.090
Receptors, Leukotriene B4
  1. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anticancer Drugs. 2007 Jun; 18(5):535-41.
    View in: PubMed
    Score: 0.074
  2. A novel anti-pancreatic cancer agent, LY293111. Anticancer Drugs. 2005 Jun; 16(5):467-73.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.